Abstract
Vascular smooth muscle biology is increasingly exploited as an interventional target in vascular disease. Vascular smooth muscle Notch3-Rho kinase-cGMP interaction has been implicated in brain and peripheral arteriopathy in CADASIL. In the present commentary, we discuss the potential implications for other, more common non-atherosclerotic microvascular diseases: INOCA and HFpEF. The relation to mechanotransduction, to cellular senescence and to sGC activators as potential intervention agents are described.
Original language | English |
---|---|
Pages (from-to) | 1209-1212 |
Number of pages | 4 |
Journal | Clinical Science |
Volume | 135 |
Issue number | 10 |
DOIs | |
Publication status | Published - May 2021 |